...
首页> 外文期刊>Pharmaceutical research >Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.
【24h】

Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.

机译:体内药物通过血脑屏障的转运预测:两种体外细胞模型之间的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Studies were conducted to evaluate whether the use of an in vitro model of the blood-brain barrier (BBB) resulted in more accurate predictions of the in vivo transport of compounds compared to the use of a human intestinal cell line (Caco-2). METHODS: The in vitro BBB model employs bovine brain capillary endothelial cells co-cultured with primary rat astrocytes. The Caco-2 cells originate from a human colorectal carcinoma. The rat was used as experimental animal for the in vivo studies. RESULTS: Strong correlations (r = 0.93-0.95) were found between the results generated by the in vitro model of the BBB and two different methodologies to measure the permeability across the BBB in vivo. In contrast, a poor correlation (r = 0.68) was obtained between Caco-2 cell data and in vivo BBB transport. A relatively poor correlation (r = 0.74) was also found between the two in vitro models. CONCLUSION: The present study illustrates the limitations of the Caco-2 model to predict BBB permeability of compounds in vivo. The results emphasize the fact that the BBB and the intestinal mucosa are two fundamentally different biologic barriers, and to be able to make accurate predictions about the in vivo CNS penetration of potential drug candidates, it is important that the in vitro model possesses the main characteristics of the in vivo BBB.
机译:目的:进行了研究以评估使用血脑屏障(BBB)体外模型是否比使用人肠道细胞系(Caco-2)能够更准确地预测化合物的体内转运)。方法:体外BBB模型采用与原代大鼠星形胶质细胞共培养的牛脑毛细血管内皮细胞。 Caco-2细胞起源于人结肠直肠癌。将该大鼠用作体内研究的实验动物。结果:在BBB体外模型产生的结果与两种不同的测量BBB体内通透性的方法之间存在强相关性(r = 0.93-0.95)。相反,Caco-2细胞数据与体内BBB转运之间的相关性较差(r = 0.68)。在两个体外模型之间还发现相对较差的相关性(r = 0.74)。结论:本研究说明了Caco-2模型在预测体内BBB通透性方面的局限性。结果强调了这样一个事实,即血脑屏障和肠粘膜是两个根本不同的生物屏障,并且为了能够对潜在的候选药物在体内的中枢神经系统渗透进行准确的预测,重要的是,体外模型应具有主要特征体内血脑屏障。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号